Bioactive Compounds
-
BA2297 MERS-CoV-IN-1Summary: Compositions of active molecules that can be used as prophylaxis against diseases caused by MERS-CoV and SARS viruses. - BA2296 LY1Summary: LY1 is a potent and selective covalent inhibitor against and.
- BA2295 SARS-CoV-2-IN-39Summary: SARS-CoV-2-IN-39 (compound 21) is an inhibitor.
- BA2294 SARS-CoV-2-IN-7Summary: SARS-CoV-2-IN-7 in SARS-CoV-2-infected VeroE6 cells in nanomoles.
- BA2293 SARS-CoV-2-IN-13Summary: SARS-CoV-2-IN-13 is a potent inhibitor.
- BA2292 SARS-CoV-2-IN-6Summary: SARS-CoV-2-IN-6 is an inhibitor that shows potent enzyme inhibitory activity.
- BA2291 HCoV-229E-IN-1Summary: HCoV-229E-IN-1 is a potent inhibitor of replication.
- BA2290 TKB245Summary: TKB245 is a potent inhibitor.
- BA2289 SSAA09E2Summary: SSAA09E2 is a novel replication inhibitor.
- BA2288 WU-04Summary: WU-04 is a non-covalent inhibitor of SARS-CoV-2 targeting the 3CLpro protein.